EUVIMEDEUVIMED entdecken
Crossref

Abstract 14738: Premature Cardiovascular Mortality Associated with Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among U.S. Adults Aged 25-64 Years, 1999-2024

Nithish Gaddam, Shreya Reddy, Jeswitha Guduguntla, MRUNJ PATEL, SAI MOURYA MEDA, Pranay Marlecha, Sweta Sahu, aravinda Nanjundappa

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.14738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Nithish Gaddam und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) are now seen as main contributing cardiometabolic conditions yet their role in premature cardiovascular death in the United States is not well defined. Research Question: We examined national trends and sex- and region-based disparities in premature cardiovascular deaths with NAFLD/NASH recorded as a contributing cause among U.S. adults aged 25-64 years.

Methods

The CDC WONDER multiple cause of death database from 1999-2024 was used to identify cardiovascular deaths using ICD-10 codes I00-I99 as underlying cause and NAFLD/NASH using codes K76.0 and K75.8 as contributing causes. We obtained death counts, population and mortality rates per 100,000 by year, sex, and census region. We assessed changes in mortality over time using log linear regression, deriving annual percent change (APC) and average annual percent change (AAPC) similar to those from joinpoint analyses.

Results

From 1999-2024, there were about 14,108 premature cardiovascular deaths due to NAFLD/NASH. Annual deaths increased from 497 in 1999 to 694 in 2024, which shows 39.6% increase and the mortality rate increased from 0.34 to 0.40 per 100,000. Trend analysis showed two inflection points, around 2016 and 2020. Mortality declined moderately from 1999-2016 (APC –0.85% per year), then increased sharply from 2016-2020 (APC +7.72% per year) and remained elevated from 2020-2024 (APC +0.90% per year) with an overall AAPC of +0.76% per year. Men reported the most deaths (9,637 vs 4,471 among women), and their mortality rates were consistently higher, but relatively stable (0.52 to 0.51 per 100,000). Women experienced a larger relative rate increase from 0.17 to 0.28 per 100,000 (+69.5%). Regionally, the West had the highest cumulative burden, followed by the South, Midwest and Northeast. The Midwest showed the largest rate increase from 0.25 to 0.55 per 100,000.

Conclusions

There was an increase in premature cardiovascular deaths in adults around the working age group in the US with NAFLD/NASH, with a steeper rise after 2016 that maintained after 2020. Though cardiometabolic mortality is common in men, there is a change in trend with a comparatively greater rise in women and in Midwestern states. These findings suggest that liver metabolic issues like NAFLD/NASH should be considered part of routine cardiovascular disease risk evaluation and prevention to reduce early deaths.

Zitieren

APA

Gaddam, N., Reddy, S., Guduguntla, J., PATEL, M., MEDA, S. M., Marlecha, P., Sahu, S., & Nanjundappa, A. (2026). Abstract 14738: Premature Cardiovascular Mortality Associated with Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among U.S. Adults Aged 25-64 Years, 1999-2024. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.14738

Vancouver

Gaddam N, Reddy S, Guduguntla J, PATEL M, MEDA SM, Marlecha P, et al. Abstract 14738: Premature Cardiovascular Mortality Associated with Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among U.S. Adults Aged 25-64 Years, 1999-2024. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.14738

BibTeX
@article{Gaddam2026,
  author = {Gaddam, Nithish and Reddy, Shreya and Guduguntla, Jeswitha and PATEL, MRUNJ and MEDA, SAI MOURYA and Marlecha, Pranay and Sahu, Sweta and Nanjundappa, aravinda},
  title = {Abstract 14738: Premature Cardiovascular Mortality Associated with Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among U.S. Adults Aged 25-64 Years, 1999-2024},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.14738}
}
Kostenlos starten →